Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | S90fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TP53 S90fs results in a change in the amino acid sequence of the Tp53 protein beginning at 90 of 393, likely resulting in premature truncation of the functional protein (UniProt.org). S90fs has not been biochemically characterized however, due to the effects of truncation mutations downstream of S90 (PMID: 31081129, PMID: 34045312), is predicted to lead to a loss of Tp53 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon4 TP53 S90fs TP53 mutant TP53 inact mut TP53 S90fs |
Transcript | NM_000546.6 |
gDNA | chr17:g.(7676101_7676102) |
cDNA | c.(268_267) |
Protein | p.S90fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126112 | chr17:g.7676106delG | c.267delC | p.S90fs*33 | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7676106delG | c.267delC | p.S90fs*33 | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7676106delG | c.267delC | p.S90fs*33 | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7676106delG | c.267delC | p.S90fs*33 | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.(7676101_7676102) | c.(268_267) | p.S90fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PIK3CA H1047R TP53 S90fs | ovarian clear cell adenocarcinoma | decreased response | DS-7423 | Preclinical - Cell culture | Actionable | In a preclinical study, an ovarian clear cell adenocarcinoma cell line harboring PIK3CA H1047R and TP53 S90fs*33 demonstrated reduced sensitivity to DS-7423 in culture (PMID: 24504419). | 24504419 |